Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

ClinicalTrials.gov ID: NCT02793583

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02793583. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 10:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

Study identification

NCT ID
NCT02793583
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
TG Therapeutics, Inc.
Industry
Enrollment
710 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2016 (Actual)
Primary completion
May 31, 2022 (Actual)
Completion
Jul 4, 2022 (Actual)
Last update posted
Jul 21, 2022

2016 – 2022

United States locations

U.S. sites
111
U.S. states
38
U.S. cities
100
Facility City State ZIP Site status
TG Therapeutics Investigational Trial Site Birmingham Alabama 35243 —
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805 —
TG Therapeutics Investigational Trial Site Chandler Arizona 85224 —
TG Therapeutics Investigational Trial Site Tucson Arizona 85711 —
TG Therapeutics Investigational Trial Site Tucson Arizona 85724 —
TG Therapeutics Investigational Trial Site Los Angeles California 90095 —
TG Therapeutics Investigational Trial Site Orange California 92868 —
TG Therapeutics Investigational Trial Site San Diego California 90710 —
TG Therapeutics Investigational Trial Site San Diego California 92108 —
TG Therapeutics Investigational Trial Site Whittier California 90603 —
TG Therapeutics Investigational Trial Site Aurora Colorado 80012 —
TG Therapeutics Investigational Trial Site Denver Colorado 80218 —
TG Therapeutics Investigational Trial Site Fort Collins Colorado 80528 —
TG Therapeutics Investigational Trial Site Bridgeport Connecticut 06606 —
TG Therapeutics Investigational Trial Site Newark Delaware 19713 —
TG Therapeutics Investigational Trial Site Washington D.C. District of Columbia 20007 —
TG Therapeutics Investigational Trial Site Boca Raton Florida 33486 —
TG Therapeutics Investigational Trial Site Fort Myers Florida 33916 —
TG Therapeutics Investigational Trial Site Gainesville Florida 32608 —
TG Therapeutics Investigational Trial Site Jacksonville Florida 32204 —
TG Therapeutics Investigational Trial Site Jacksonville Florida 32224 —
TG Therapeutics Investigational Trial Site Jacksonville Florida 32256 —
TG Therapeutics Investigational Trial Site Miami Florida 33176 —
TG Therapeutics Investigational Trial Site St. Petersburg Florida 33705 —
TG Therapeutics Investigational Trial Site Tallahassee Florida 32308 —
TG Therapeutics Investigational Trial Site Tampa Florida 33612 —
TG Therapeutics Investigational Trial Site West Palm Beach Florida 33407 —
TG Therapeutics Investigational Trial Site Albany Georgia 31701 —
TG Therapeutics Investigational Trial Site Macon Georgia 31201 —
TG Therapeutics Investigational Trial Site Marietta Georgia 30060 —
TG Therapeutics Investigational Trial Site Chicago Illinois 60612 —
TG Therapeutics Investigational Trial Site Chicago Illinois 60637 —
TG Therapeutics Investigational Trial Site Decatur Illinois 62526 —
TG Therapeutics Investigational Trial Site Evanston Illinois 60201 —
TG Therapeutics Investigational Trial Site Harvey Illinois 60426 —
TG Therapeutics Investigational Trial Site Maywood Illinois 60153 —
TG Therapeutics Investigational Trial Site Niles Illinois 60714 —
TG Therapeutics Investigational Trial Site Peoria Illinois 61615 —
TG Therapeutics Investigational Trial Site Swansea Illinois 62226 —
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46845 —
TG Therapeutics Investigational Trial Site Indianapolis Indiana 46237 —
TG Therapeutics Investigational Trial Site Westwood Kansas 66210 —
TG Therapeutics Investigational Trial Site Louisville Kentucky 40207 —
TG Therapeutics Investigational Trial Site Covington Louisiana 70433 —
TG Therapeutics Investigational Trial Site Brewer Maine 04412 —
TG Therapeutics Investigational Trial Site Baltimore Maryland 21201 —
TG Therapeutics Investigational Trial Site Bethesda Maryland 20817 —
TG Therapeutics Investigational Trial Site Columbia Maryland 21044 —
TG Therapeutics Investigational Trial Site Towson Maryland 21204 —
TG Therapeutics Investigational Trial Site Ann Arbor Michigan 48109 —
TG Therapeutics Investigational Trial Site Duluth Minnesota 55805 —
TG Therapeutics Investigational Trial Site Saint Louis Park Minnesota 55416 —
TG Therapeutics Investigational Trial Site Columbia Missouri 65212 —
TG Therapeutics Investigational Trial Site Kansas City Missouri 64132 —
TG Therapeutics Investigational Trial Site St Louis Missouri 63110 —
TG Therapeutics Investigational Trial Site Billings Montana 59102 —
TG Therapeutics Investigational Trial Site Lincoln Nebraska 68510 —
TG Therapeutics Investigational Trial Site Omaha Nebraska 68130 —
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756 —
TG Therapeutics Investigational Trial Site Hackensack New Jersey 07601 —
TG Therapeutics Investigational Trial Site Morristown New Jersey 07962 —
TG Therapeutics Investigational Trial Site Mount Holly New Jersey 08060 —
TG Therapeutics Investigational Trial Site Farmington New Mexico 87401 —
TG Therapeutics Investigational Trial Site Buffalo New York 14263 —
TG Therapeutics Investigational Trial Site New York New York 10019 —
TG Therapeutics Investigational Trial Site Syracuse New York 13210 —
TG Therapeutics Investigational Trial Site The Bronx New York 10467 —
TG Therapeutics Investigational Trial Site Charlotte North Carolina 28201 —
TG Therapeutics Investigational Trial Site Durham North Carolina 27705 —
TG Therapeutics Investigational Trial Site Hickory North Carolina 28602 —
TG Therapeutics Investigational Trial Site Kinston North Carolina 28501 —
TG Therapeutics Investigational Trial Site Raleigh North Carolina 27607 —
TG Therapeutics Investigational Trial Site Washington North Carolina 27889 —
TG Therapeutics Investigational Trial Site Canton Ohio 44718 —
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45220 —
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45242 —
TG Therapeutics Investigational Trial Site Cleveland Ohio 44106 —
TG Therapeutics Investigational Trial Site Columbus Ohio 43219 —
TG Therapeutics Investigational Trial Site Toledo Ohio 43623 —
TG Therapeutics Investigational Trial Site Portland Oregon 97213 —
TG Therapeutics Investigational Trial Site Portland Oregon 97227 —
TG Therapeutics Investigational Trial Site Springfield Oregon 97477 —
TG Therapeutics Investigational Trial Site Camp Hill Pennsylvania 17011 —
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19106 —
TG Therapeutics Investigational Trial Site Providence Rhode Island 02906 —
TG Therapeutics Investigational Trial Site Greenville South Carolina 29615 —
TG Therapeutics Investigational Trial Site Sioux Falls South Dakota 57105 —
TG Therapeutics Investigational Trial Site Watertown South Dakota 57201 —
TG Therapeutics Investigational Trial Site Chattanooga Tennessee 37404 —
TG Therapeutics Investigational Trial Site Kingsport Tennessee 37660 —
TG Therapeutics Investigational Trial Site Knoxville Tennessee 37916 —
TG Therapeutics Investigational Trial Site Memphis Tennessee 38120 —
TG Therapeutics Investigational Trial Site Austin Texas 78705 —
TG Therapeutics Investigational Trial Site Dallas Texas 75390 —
TG Therapeutics Investigational Trial Site Fort Sam Houston Texas 78234 —
TG Therapeutics Investigational Trial Site Houston Texas 77030 —
TG Therapeutics Investigational Trial Site San Antonio Texas 78130 —
TG Therapeutics Investigational Trial Site San Antonio Texas 78217 —
TG Therapeutics Investigational Trial Site San Antonio Texas 78229 —
TG Therapeutics Investigational Trial Site Tyler Texas 75702 —
TG Therapeutics Investigational Trial Site Ogden Utah 84403 —
TG Therapeutics Investigational Trial Site Blacksburg Virginia 24060 —
TG Therapeutics Investigational Trial Site Newport News Virginia 23601 —
TG Therapeutics Investigational Trial Site Olympia Washington 98502 —
TG Therapeutics Investigational Trial Site Seattle Washington 98104 —
TG Therapeutics Investigational Trial Site Seattle Washington 98108 —
TG Therapeutics Investigational Trial Site Seattle Washington 98109 —
TG Therapeutics Investigational Trial Site Spokane Washington 99216 —
TG Therapeutics Investigational Trial Site Vancouver Washington 97277 —
TG Therapeutics Investigational Trial Site Madison Wisconsin 53792 —
TG Therapeutics Investigational Trial Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02793583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2022 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.